APA (7th ed.) Citation

Tang, Q., Zhang, X., Zhu, X., Xu, H., Song, G., Lu, J., . . . Wang, J. Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory phase II trial. Wiley.

Chicago Style (17th ed.) Citation

Tang, Qinglian, et al. Camrelizumab in Combination with Doxorubicin, Cisplatin, Ifosfamide, and Methotrexate in Neoadjuvant Treatment of Resectable Osteosarcoma: A Prospective, Single‐arm, Exploratory Phase II Trial. Wiley.

MLA (9th ed.) Citation

Tang, Qinglian, et al. Camrelizumab in Combination with Doxorubicin, Cisplatin, Ifosfamide, and Methotrexate in Neoadjuvant Treatment of Resectable Osteosarcoma: A Prospective, Single‐arm, Exploratory Phase II Trial. Wiley.